Investor

The rounds this investor is named on, who it invests beside, and where it shows up.

Polaris Partners: 1 round · Fireround

Soufflé Therapeutics, Inc.[ PART ]

A leading RNA therapies company aimed at advancing the next generation of therapies designed to help people live healthier lives

Series B$135M2026-10-134

Company	Round	Amount	Announced	Role
Soufflé Therapeutics, Inc. A leading RNA therapies company aimed at advancing the next generation of therapies designed to help people live healthier lives	Series B Verified against 3 of 4 sources	$135M	2026-10-13	[ PART ]